All In Biotech

Free tool

FAERS Monitor: Amiodarone Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021594 or its brand name (Amiodarone Hydrochloride, Amiodarone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,185

Serious

7,993

87% of reports

Hospitalization

4,599

Death reported

1,582

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea997
  • off label use869
  • asthenia835
  • fatigue770
  • drug ineffective688
  • product use in unapproved indication648
  • nausea545
  • cough528
  • dizziness471
  • atrial fibrillation465
  • pneumonia449
  • vomiting439
  • drug interaction417
  • hypotension417
  • condition aggravated407

Reports by year received

View as table
YearReports
200459
2005106
200683
200768
200841
2009108
2010119
2011140
2012332
2013144
2014142
2015157
2016179
2017492
2018479
2019596
2020592
2021833
2022916
2023916
20241,042
20251,033
2026606

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,974 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
atrial fibrillationSignal46511.010.04,208
drug interactionSignal4176.05.51,754
product use in unapproved indicationSignal6486.05.62,720
astheniaSignal8355.14.82,787
hypotensionSignal4174.84.31,247
coughSignal5284.34.01,358
dyspnoeaSignal9974.03.82,335
pneumoniaSignal4493.22.9678
condition aggravatedSignal4073.12.8573
off label useSignal8692.32.1645
fatigueSignal7702.32.1564
dizzinessSignal4712.22.0300
vomitingSignal4392.12.0271
nausea5451.61.5119
drug ineffective6881.21.123

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.